Steele Capital Management Inc. Makes New $514,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Steele Capital Management Inc. purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,786 shares of the financial services provider’s stock, valued at approximately $514,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of IBB. International Assets Investment Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $76,425,000. Itau Unibanco Holding S.A. purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $48,242,000. Tower Research Capital LLC TRC increased its stake in shares of iShares Biotechnology ETF by 28,138.4% during the third quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock worth $12,052,000 after buying an additional 98,203 shares during the period. Calamos Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $7,648,000. Finally, Cumberland Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $6,297,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

IBB traded up $1.88 on Monday, reaching $128.37. The company’s stock had a trading volume of 1,761,053 shares, compared to its average volume of 1,795,517. The stock has a 50 day moving average of $134.12 and a two-hundred day moving average of $129.88. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.